Shengli Cao
-
- MicroRNA in disease regulation 3
-
- Liver Disease and Transplantation 7
-
- RNA modifications and cancer 4
- Heme Oxygenase-1 and Carbon Monoxide 4
-
- Organ Transplantation Techniques and Outcomes 8
-
- Liver Disease Diagnosis and Treatment 4
-
- Endoplasmic Reticulum Stress and Disease 4
-
- Drug-Induced Hepatotoxicity and Protection 3
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (1 paper)Scientific Reports (1 paper)
- Partner nations
- China
In The Last Decade
Shengli Cao
30 papers receiving 381 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 157
- Hepatology 28
- Molecular Biology 239
- Endocrine and Autonomic Systems 22
- Transplantation 6
Countries citing papers authored by Shengli Cao
This map shows the geographic impact of Shengli Cao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengli Cao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengli Cao more than expected).
Fields of papers citing papers by Shengli Cao
This network shows the impact of papers produced by Shengli Cao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengli Cao. The network helps show where Shengli Cao may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shengli Cao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 8 | |
| 4 | 2022 | 8 | |
| 5 | 2022 | 0 | |
| 6 | 2021 | 13 | |
| 7 | 2021 | 7 | |
| 8 | 2021 | 4 | |
| 9 | 2021 | 6 | |
| 10 | 2021 | 9 | |
| 11 | 2020 | 4 | |
| 12 | 2017 | 4 | |
| 13 | 2017 | 52 | |
| 14 | 2015 | 31 | |
| 15 | 2015 | 7 | |
| 16 | 2015 | 10 | |
| 17 | 2014 | 22 | |
| 18 | 2014 | 10 | |
| 19 | 2014 | 10 | |
| 20 | [Expression of Piwil2 and its relationship with tumor invasion and metastasis in papillary thyroid carcinoma]. | 2011 | 6 |
About Shengli Cao
Shengli Cao is a scholar working on Hepatology, Pharmacology and Biochemistry, having authored 32 papers that have together received 387 indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (8 papers), Liver Disease and Transplantation (7 papers), Liver Disease Diagnosis and Treatment (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers), RNA modifications and cancer (4 papers), Heme Oxygenase-1 and Carbon Monoxide (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers) and MicroRNA in disease regulation (3 papers). The work is most often cited by research in Cancer Research (157 citations), Hepatology (28 citations) and Molecular Biology (239 citations). Shengli Cao has collaborated with scholars based in China. Frequent co-authors include Shuijun Zhang, Wenzhi Guo, Jiakai Zhang, Peihao Wen, Zhihui Wang, Xiaoyi Shi, Bing Yan, Jie Pan, Yang Han and Hua Ye. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.